Share This!
Text SizeAAA Share Email

Preservation of Antibiotics for Medical Treatment Act

Antibiotic resistance is a growing crisis. The overuse of antibiotics in both human medicine and animal agriculture contributes to the rise of antibiotic-resistant infections that are costly and difficult to treat. Moreover, the burden of antibiotic resistance is borne by the most vulnerable members of our society: children, the elderly, and individuals whose immune systems are already weakened, such as people undergoing chemotherapy or those with HIV/AIDS.

Become a PAMTA Endorser!

If your organization would like to help solve the problem of antibiotic overuse in agriculture, join the list of over 450 health, agriculture, environment, food and hunger, animal protection, religious, public interest, labor and other groups that have endorsed PAMTA!

But while doctors are actively curtailing unnecessary uses of antibiotics in human medicine, operators of CAFOs (confined animal feeding operations) continue to use vast quantities of these priceless drugs every day in the feed and water of animals that are not even sick.

Within two years of enactment, the Preservation of Antibiotics for Medical Treatment Act (PAMTA) would require the Food and Drug Administration (FDA) to re-review the approvals it previously issued for animal feed uses of the seven classes of antibiotics that are important to human medicine. The approvals would be canceled for any antibiotics that are found to be unsafe from a resistance point of view.

CAFO operators add human antibiotics to the feed of animals to accelerate animal growth and prevent diseases common in overcrowded and unsanitary living conditions. According to the FDA, 80 percent of the antibiotics produced in this country are used in animal agriculture, the vast majority for these nontherapeutic purposes. This amount is estimated to be more than four times the amount of drugs used to treat human illness.

Antibiotic resistance linked to food animal operations is on the rise. Studies suggest that hog farms are a source of a new strain (ST398) of MRSA (Methicillin-resistant Staphylococcus aureus), a disease responsible for more deaths per year in the United States than AIDS.

The FDA is aware of the problem of antibiotic resistance due to overuse in animal agriculture, but the agency's process for reviewing and withdrawing drugs from the market is far too slow and cumbersome. A recent effort to withdraw an antibiotic from use by poultry producers due to concerns about human antibiotic resistance lasted for more than five years, costing millions of taxpayer dollars. And while the judicial proceedings dragged on, disease-causing bacteria continued to outwit antibiotics.
 
Although some producers and retailers of meat products have announced policies that take steps to curb antibiotic use, private-sector initiatives to reduce antibiotic use in animal agriculture are relatively rare, limited in scope, and difficult to verify. Federal action is needed to achieve comprehensive reductions and create a level playing field for all producers and retailers.

Passage of PAMTA is critical to keep antibiotics working for human health. In addition to averting the harmful effects of antibiotic overuse on human health, curtailing animal use of antibiotics will encourage producers to raise animals in better living conditions that are less conducive to disease.

The American Medical Association and hundreds of other health, consumer, environmental, agricultural, and humane organizations support this legislation, which expired with the end of the 112th Congress but is expected to be re-introduced soon.

Powered by Convio
nonprofit software